Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2154288rdf:typepubmed:Citationlld:pubmed
pubmed-article:2154288lifeskim:mentionsumls-concept:C0684336lld:lifeskim
pubmed-article:2154288lifeskim:mentionsumls-concept:C0027410lld:lifeskim
pubmed-article:2154288lifeskim:mentionsumls-concept:C0206249lld:lifeskim
pubmed-article:2154288pubmed:issue2lld:pubmed
pubmed-article:2154288pubmed:dateCreated1990-3-19lld:pubmed
pubmed-article:2154288pubmed:abstractTextRats (n = 20) were injected with the opioid antagonist naltrexone and half were exposed to inescapable shock/restraint. Another 20 rats were injected with saline and half were exposed to shock. Neither saline nor naltrexone alone had any effect on hippocampal LTP. A large reduction in LTP was observed in saline rats exposed to shock, while normal LTP developed in the naltrexone rats exposed to shock. Thus, naltrexone eliminated the impairment, and thereby implicated endogenous opioids in the mechanism responsible for the stress-induced impairment of LTP.lld:pubmed
pubmed-article:2154288pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2154288pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2154288pubmed:languageenglld:pubmed
pubmed-article:2154288pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2154288pubmed:citationSubsetIMlld:pubmed
pubmed-article:2154288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2154288pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2154288pubmed:statusMEDLINElld:pubmed
pubmed-article:2154288pubmed:monthJanlld:pubmed
pubmed-article:2154288pubmed:issn0006-8993lld:pubmed
pubmed-article:2154288pubmed:authorpubmed-author:LevineSSlld:pubmed
pubmed-article:2154288pubmed:authorpubmed-author:ThompsonR FRFlld:pubmed
pubmed-article:2154288pubmed:authorpubmed-author:ShorsT JTJlld:pubmed
pubmed-article:2154288pubmed:issnTypePrintlld:pubmed
pubmed-article:2154288pubmed:day8lld:pubmed
pubmed-article:2154288pubmed:volume506lld:pubmed
pubmed-article:2154288pubmed:ownerNLMlld:pubmed
pubmed-article:2154288pubmed:authorsCompleteYlld:pubmed
pubmed-article:2154288pubmed:pagination316-8lld:pubmed
pubmed-article:2154288pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:meshHeadingpubmed-meshheading:2154288-...lld:pubmed
pubmed-article:2154288pubmed:year1990lld:pubmed
pubmed-article:2154288pubmed:articleTitleOpioid antagonist eliminates the stress-induced impairment of long-term potentiation (LTP).lld:pubmed
pubmed-article:2154288pubmed:affiliationUniversity of Southern California, Department of Psychology, Los Angeles 90089.lld:pubmed
pubmed-article:2154288pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2154288pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2154288pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2154288pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2154288lld:pubmed